Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pancreatic Cancer, Early Drug Development

Davide Melisi

MD

🏢University of Verona🌐Italy

Associate Professor of Medical Oncology

36
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Davide Melisi at the University of Verona is an Italian pancreatic cancer investigator and early drug development expert. His research on TGF-beta pathway inhibition in pancreatic cancer stroma has generated novel combination hypotheses. He has led multiple first-in-human and phase II trials of novel agents in pancreatic cancer and is a principal investigator in ITMO (Italian Trials in Medical Oncology) cooperative group studies.

Share:

🧪Research Fields 研究领域

pancreatic cancer
TGF-beta inhibition
early phase trials
gemcitabine combinations
stromal targeting

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Davide Melisi 的研究动态

Follow Davide Melisi's research updates

留下邮箱,当我们发布与 Davide Melisi(University of Verona)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment